Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizios Significant Role in Detection of Esophageal Dysplasia and Cancer
Results demonstrate a significant increase in the detection rate of neoplasia when Cellvizio is used as an adjunct to the standard of care, underscoring the key role of advanced imaging in slowing the rapid growth of esophageal cancer
Meta-analysis buil... Devices, Diagnostics, Oncology Mauna Kea Technologies, Cellvizio, Barretts Esophagus, Esophageal Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2022 Category: Pharmaceuticals Source Type: news
Cancer warning: The hot drink that may be associated with a 90% higher risk of cancer
CANCER risk can be modified through the lifestyle decisions you make. One of the more alarming findings to date is that knocking back a particularly hot drink may hike your risk of oesophageal cancer by 90 percent. (Source: Daily Express - Health)
Source: Daily Express - Health - July 6, 2022 Category: Consumer Health News Source Type: news
Cancer symptoms: The ‘common’ sign when you eat that appears in the ‘early stages'
WHILE there are various symptoms linked to oesophageal cancer, their generic nature might make them difficult to spot. As this type of cancer claims thousands of lives yearly, being able to recognise the symptoms could help spot the diagnosis early. An expert shares a "common" sign that appears in the "early stages". (Source: Daily Express - Health)
Source: Daily Express - Health - June 26, 2022 Category: Consumer Health News Source Type: news
Kim Kardashian shares Father's Day tributes to Ye and her late dad
The 41-year-old reality star was 22 when her father died, age 59, from esophageal cancer in 2003 (Source: Reuters: Health)
Source: Reuters: Health - June 19, 2022 Category: Consumer Health News Source Type: news
How Do You Detect Esophageal Cancer?
Title: How Do You Detect Esophageal Cancer?Category: Diseases and ConditionsCreated: 6/16/2022 12:00:00 AMLast Editorial Review: 6/16/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 16, 2022 Category: Cancer & Oncology Source Type: news
Main Causes of Esophageal Cancer
Title: Main Causes of Esophageal CancerCategory: Diseases and ConditionsCreated: 4/23/2021 12:00:00 AMLast Editorial Review: 6/8/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 8, 2022 Category: Cancer & Oncology Source Type: news
Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA ® (erdafitinib) in Patients with Advanced Solid Tumors with FGFR Alterations
CHICAGO, ILLINOIS, June 7, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the pivotal Phase 2 RAGNAR study evaluating the investigational use of BALVERSA® (erdafitinib), a fibroblast growth factor receptor (FGFR) kinase inhibitor, in patients with advanced solid tumors with prespecified FGFR alterations. At a planned interim analysis (IA), responses were observed across a variety of FGFR-driven solid tumors for patients who had exhausted standard treatment options prior to being treated with BALVERSA®.[1] These results will be featured in an oral presentation (...
Source: Johnson and Johnson - June 7, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Rates of esophageal cancer among middle-aged Americans doubled over a five year period
The rate of middle-aged Americans developing esophageal cancer nearly doubled from 2012 to 2017, a new study finds. Researchers were unable to nail down an exact cause for this increase. (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2022 Category: Consumer Health News Source Type: news
FDA approves Opdivo in combination with chemotherapy and Opdivo in combination with Yervoy for first-line esophageal squamous cell carcinoma indications
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 31, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Esophageal cancer may be rising among the middle-aged
Among those ages 45 to 64, the esophageal cancer rate nearly doubled from 2012 to 2019, according to estimates from the American Cancer Society. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 31, 2022 Category: Consumer Health News Authors: Linda Searing Source Type: news
Immunotherapy Now First Line for Esophageal Cancer Immunotherapy Now First Line for Esophageal Cancer
Nivolumab (Opdivo) with chemotherapy or in combination with ipilimumab (Yervoy) has been approved by the FDA for first-line use in the treatment of unresectable advanced or metastatic esophageal cancer.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 30, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
U.S. Food and Drug Administration Approves Two Opdivo (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Opdivo in combination with chemotherapy and Opdivo plus Yervoy® (ipilimumab) approved based on a Phase 3 trial showing improved overall survival versus chemotherapy alone1,2
Opdivo-based treatments are now approved for five indications in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 30, 2022 Category: Drugs & Pharmacology Source Type: news
Biomarker Panel to Detect Esophageal Squamous Cell Cancer (ESCC) Biomarker Panel to Detect Esophageal Squamous Cell Cancer (ESCC)
A biomarker panel used on tissue samples obtained via a swallowable capsule can detect esophageal squamous cell cancer (ESCC) and may be particularly useful where endoscopy is not widely available.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 25, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
Surgery Delay Shortens Survival of Patients With Advanced Esophageal Cancer Surgery Delay Shortens Survival of Patients With Advanced Esophageal Cancer
Delays in surgery for advanced esophageal cancer, such as those implemented in the first months of the COVID-19 pandemic, result in significantly worse outcomes, a new analysis found.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 24, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
Survival Similar for Early, Delayed Surgery in Stage I Esophageal Cancer
For patients with stage II/III esophageal cancer, five - year survival is improved with early versus delayed esophagectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 23, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Internal Medicine, Oncology, Radiology, Surgery, Journal, Source Type: news
